Objective To study the predictive effect of glial fibrillary acidic protein (GFAP) on the non ⁃ thrombolytic hemorrhagic transformation in brain infarction patients. Methods In this study there were 78 acute brain infarct patients at the mean age of (62.85 ± 11.18) years old. Fifty⁃two patients were males (66.67%) and 26 were females (33.33%). All patients were admitted to the hospital less than 72 hours after onset. No hemorrhagic findings were seen on the head magnetic resonance imaging (MRI) (including multiplanar gradient ⁃ recalled echo) in the patients. All of them were not selected for thrombolytic therapy. On 7-10 d after the first MRI at the onset, low signal for hemorrhagic transformation was seen on multiplanar gradient⁃recalled ...
The purpose of this study was to correlate the early levels of glial fibrillary acidic protein (GFAP...
Glial fibrillary acidic protein (GFAP) is a biomarker candidate indicative of intracerebral hemorrha...
BACKGROUND: There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrill...
<p><strong>Background:</strong> Stroke is one of the root causes of brain disorders at the height of...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
BACKGROUND AND PURPOSE: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Objective: It was aimed to determine whether levels of glial fibrillary acidic protein (GFAP) and Ga...
Item does not contain fulltextBACKGROUND: In the present study, a new assay for the measurement of g...
Background and Purpose—We tested the hypothesis that proteins of hemostasia could be associated with...
Background: The extensive use of computed tomography (CT) after acute head injury is costly and carr...
BACKGROUND: There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrill...
Background: Whether there is a relationship between glomerular filtration rate (GFR) and hemorrhagic...
Background: The extensive use of computed tomography (CT) after acute head injury is costly and carr...
Glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein, can be measured in blood...
The purpose of this study was to correlate the early levels of glial fibrillary acidic protein (GFAP...
Glial fibrillary acidic protein (GFAP) is a biomarker candidate indicative of intracerebral hemorrha...
BACKGROUND: There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrill...
<p><strong>Background:</strong> Stroke is one of the root causes of brain disorders at the height of...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
BACKGROUND AND PURPOSE: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Background and Purpose: The brain-specific astroglial protein GFAP is a blood biomarker candidate in...
Objective: It was aimed to determine whether levels of glial fibrillary acidic protein (GFAP) and Ga...
Item does not contain fulltextBACKGROUND: In the present study, a new assay for the measurement of g...
Background and Purpose—We tested the hypothesis that proteins of hemostasia could be associated with...
Background: The extensive use of computed tomography (CT) after acute head injury is costly and carr...
BACKGROUND: There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrill...
Background: Whether there is a relationship between glomerular filtration rate (GFR) and hemorrhagic...
Background: The extensive use of computed tomography (CT) after acute head injury is costly and carr...
Glial fibrillary acidic protein (GFAP), an astrocytic cytoskeletal protein, can be measured in blood...
The purpose of this study was to correlate the early levels of glial fibrillary acidic protein (GFAP...
Glial fibrillary acidic protein (GFAP) is a biomarker candidate indicative of intracerebral hemorrha...
BACKGROUND: There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrill...